Dear Researchers,
We are pleasure to share our
citation weekly report VOL66 with you.
On August 25, 2021, Krina T.
Zondervan from University of Oxford, Women's Centre, John Radcliffe Hospital,
and his team published a paper titled "Neuropeptide S receptor 1 is a
nonhormonal treatment target in endometriosis" on Science
Translational Medicine. They concluded that the NPSR1/NPS system is a
genetically validated, nonhor[1]monal target for the
treatment of endometriosis with likely increased relevance to stage III/IV
disease.
ELISA Kit for Neuropeptide S (NPS)
Packages (Simulation)
(주)엘바이오시스템은 Cloud-Clone의 한국공식대리점입니다.
제품의 주문 및 관련정보가 필요하시면 전화,팩스,이메일로 문의해 주세요.